Aurora A. Miranda
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Aurora A. Miranda has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
Andreas P. Pintado-Urbanc
1 shared publication- Courtney L. Brown
Yale Combined Program in the Biological and Biomedical Sciences, Yale University
1 shared publication Joshua T. Young
1 shared publication- Matthew D. Simon
Yale University
1 shared publication - Morgan M. Kennebeck
Department of Chemistry University of Illinois Urbana-Champaign 600 South Mathews Avenue Urbana IL-61801 USA
1 shared publication - Robert D. Boyd
Department of Chemistry University of Illinois Urbana-Champaign 600 South Mathews Avenue Urbana IL-61801 USA
1 shared publication
Latest Publications
- Open Access
- 17 November 2026
- Published by Elsevier in Journal of Biological Chemistry
The histone deacetylase inhibitor romidepsin increases cellular acetyl-methyllysine
- 17 November 2026
- Published by Elsevier in Journal of Biological Chemistry
Open AccessThe histone deacetylase inhibitor romidepsin increases cellular acetyl-methyllysine
- Open Access
- 25 July 2024
- Published by Oxford University Press (OUP) in Nucleic Acids Research
- Vol. 52 (15) , 8702-8716
Site-specific N-alkylation of DNA oligonucleotide nucleobases by DNAzyme-catalyzed reductive amination
DNA and RNA nucleobase modifications are biologically relevant and valuable in fundamental biochemical and biophysical investigations of nucleic acids. However, directly introducing site-specific nucleobase modifications into long unprotected oligonucleotides is a substantial challenge. In this study, we used in vitro selection to identify DNAzymes that site-specifically N-alkylate the exocyclic nucleobase amines of particular cytidine, guanosine, and adenosine (C, G and A) nucleotides in DNA substrates, by reductive amination using a 5′-benzaldehyde oligonucleotide as the reaction partner. The new DNAzymes each require one or more of Mg2+, Mn2+, and Zn2+ as metal ion cofactors and have kobs from 0.04 to 0.3 h–1, with rate enhancement as high as ∼104 above the splinted background reaction. Several of the new DNAzymes are catalytically active when an RNA substrate is provided in place of DNA. Similarly, several new DNAzymes function when a small-molecule benzaldehyde compound replaces the 5′-benzaldehyde oligonucleotide. These findings expand the scope of DNAzyme catalysis to include nucleobase N-alkylation by reductive amination. Further development of this new class of DNAzymes is anticipated to facilitate practical covalent modification and labeling of DNA and RNA substrates.
- 25 July 2024
- Published by Oxford University Press (OUP) in Nucleic Acids Research
- Vol. 52 (15) , 8702-8716
Open AccessSite-specific N-alkylation of DNA oligonucleotide nucleobases by DNAzyme-catalyzed reductive amination
DNA and RNA nucleobase modifications are biologically relevant and valuable in fundamental biochemical and biophysical investigations of nucleic acids. However, directly introducing site-specific nucleobase modifications into long unprotected oligonucleotides is a substantial challenge. In this study, we used in vitro selection to identify DNAzymes that site-specifically N-alkylate the exocyclic nucleobase amines of particular cytidine, guanosine, and adenosine (C, G and A) nucleotides in DNA substrates, by reductive amination using a 5′-benzaldehyde oligonucleotide as the reaction partner. The new DNAzymes each require one or more of Mg2+, Mn2+, and Zn2+ as metal ion cofactors and have kobs from 0.04 to 0.3 h–1, with rate enhancement as high as ∼104 above the splinted background reaction. Several of the new DNAzymes are catalytically active when an RNA substrate is provided in place of DNA. Similarly, several new DNAzymes function when a small-molecule benzaldehyde compound replaces the 5′-benzaldehyde oligonucleotide. These findings expand the scope of DNAzyme catalysis to include nucleobase N-alkylation by reductive amination. Further development of this new class of DNAzymes is anticipated to facilitate practical covalent modification and labeling of DNA and RNA substrates.